Author:
Huang Shyhmin,Peter Rodemann H.,Harari Paul M.
Publisher
Springer Berlin Heidelberg
Reference243 articles.
1. Ahsan A, Hiniker SM, Davis MA, Lawrence TS, Nyati MK (2009) Role of cell cycle in epidermal growth factor receptor inhibitor-mediated radiosensitization. Cancer Res 69:5108–5114
2. Akimoto T, Hunter NR, Buchmiller L, Mason K, Ang KK, Milas L (1999) Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas. Clin Cancer Res 5:2884–2890
3. Al-Ejeh F, Shi W, Miranda M, Simpson PT, Vargas AC, Song S, Wiegmans AP, Swarbrick A, Welm AL, Brown MP, Chenevix-Trench G, Lakhani SR, Khanna KK (2013) Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor. J Nucl Med 54:913–921
4. Allegra CJ, Jessup JM, Somerfield MR, Hamilton SR, Hammond EH, Hayes DF, McAllister PK, Morton RF, Schilsky RL (2009) American Society of clinical oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol 27:2091–2096
5. Allen GW, Saba C, Armstrong EA, Huang S-M, Benavente S, Ludwig DL, Hicklin DJ, Harari PM (2007) Insulin-like growth factor-i receptor signaling blockade combined with radiation. Cancer Res 67:1155–1162
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献